retatrutide clinical trial status Michael Weintraub, MD on X: "Looking forward to when #retatrutide's Phase 3 results will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its Lilly's triple agonist, retatrutide, delivered

Importantly, Contrave isnt suitable for everyone

This is particularly important given the dosing schedule and potential side effects associated with starting and stopping GLP-1 drugs

Ideal for recomposition or cutting without muscle loss

Long-term Drug Treatment for Obesity: A Systematic and Clinical Review

While murine models suggest atrial GLP-1R expression, the precise cardiac cell types expressing GLP-1R, especially in humans, are yet to be conclusively identified [33]

Notably, no cases of clinically significant hypoglycemia, medullary thyroid cancer, or C-cell hyperplasia were reported in published trial data